Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients.
Brittni M UseraPolly CrevelingJonathan D TwardPublished in: Prostate cancer (2020)
In men with serum testosterone levels >=100 ng/dl at diagnosis, baseline testosterone does not impact PFS, MFS, or OS. Recovery of testosterone back to baseline is expected for men undergoing either surgery, external beam or brachytherapy, or combined modality radiation when not using ADT.
Keyphrases
- replacement therapy
- prostate cancer
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- high dose
- smoking cessation
- radiation therapy
- radical prostatectomy
- type diabetes
- squamous cell carcinoma
- peritoneal dialysis
- coronary artery bypass
- radiation induced
- locally advanced
- metabolic syndrome
- patient reported outcomes
- low dose
- coronary artery disease
- rectal cancer